SCHEMBL734841

SCHEMBL734841

CC1C(=O)N(CCCCN2CCC3(CC3)C(O)C2)CCN1c1ccc(Cl)c(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 12/20 0.36
MMP2 P08253 11/20 0.36
MMP14 P50281 4/20 0.36
ADAMTS4 O75173 1/20 0.36
MMP13 P45452 2/20 0.35
ADAM17 P78536 3/20 0.35
HTR7 P34969 2/20 0.35
KCNH2 Q12809 2/20 0.34
DRD2 P14416 3/20 0.33
DRD4 P21917 1/20 0.33
BCL2A1 Q16548 1/20 0.33
HTR1A P08908 1/20 0.33
HTR2A P28223 1/20 0.33
HTR6 P50406 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734840 1.00 ADAMTS5 (0.36) ADAMTS5MMP2MMP14ADAMTS4MMP13
SCHEMBL733841 0.98 ADAMTS5 (0.36) ADAMTS5MMP2MMP14ADAMTS4MMP13
SCHEMBL737169 0.98 ADAMTS5 (0.36) ADAMTS5MMP2MMP14ADAMTS4MMP13
SCHEMBL736169 0.98 ADAMTS5 (0.36) ADAMTS5MMP2MMP14ADAMTS4MMP13
SCHEMBL733840 0.98 ADAMTS5 (0.36) ADAMTS5MMP2MMP14ADAMTS4MMP13
SCHEMBL736112 0.91 ADAMTS5 (0.40) ADAMTS5MMP2MMP14ADAMTS4MMP13
SCHEMBL736545 0.91 ADAMTS5 (0.40) ADAMTS5MMP2MMP14ADAMTS4MMP13
SCHEMBL736111 0.91 ADAMTS5 (0.40) ADAMTS5MMP2MMP14ADAMTS4MMP13
SCHEMBL735738 0.88 SLC6A2 (0.35) ADAMTS5MMP2MMP14ADAMTS4MMP13
SCHEMBL736670 0.88 SLC6A2 (0.35) ADAMTS5MMP2MMP14ADAMTS4MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138175-B2 Heterocyclyl compounds HOFFMANN-LA ROCHE INC. (US) 2012-03-20 US claimed
US-20100022518-A1 NOVEL HETEROCYCLYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-01-28 US claimed
US-8138175-B2 Heterocyclyl compounds HOFFMANN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100022518-A1 NOVEL HETEROCYCLYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022518-A1 NOVEL HETEROCYCLYL COMPOUNDS CCR2, CCR3, CCR5 ADAMTS5 4707/4885MMP2 3027/4885MMP14 4537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.